If there's one thing (other than Donald Trump's promised ban) that can stop Big Pharma chemically and surgically mutilating confused children for money, it's losing law suits later filed by some of the victims. So it's great news that a leading U.S. doctor prescribing ‘sex-change’ medication and surgery to children is being sued for medical negligence.
At just 12 years old, and only months into questioning her ‘gender identity’, Clementine Breen was prescribed surgically-implanted puberty blockers at her first appointment with Dr Olsen-Kennedy at the Center for Transyouth Health and Development in Los Angeles.
Just three months later, a puberty-blocking device was inserted into her arm, and within another twelve months, began cross-sex hormone treatment to make her appear more masculine. At 14 she underwent a double mastectomy.
Now 22, she has ‘detransitioned’ and has been speaking out on how children are unable to consent to such harmful and irreversible procedures. She has filed a lawsuit against the medical practitioners responsible.
Documents submitted to the court accuse Dr Olsen-Kennedy of coercing Clementine’s hesitant parents into backing their daughter’s ‘trans-affirming care’ by suggesting that “if they did not agree to cross-sex hormone therapy, Clementine would commit suicide.”
The doctor is also alleged to have falsely claimed that the girl had “endorsed a male gender identity since childhood”, whereas the detransitioner now states: “I wasn’t really sure about my identity at all”.
University of California, Los Angeles student Breen shared on social media: “my double mastectomy should have never happened considering at the time I had just experienced sexual abuse for the second time in my life, which was considered irrelevant as to why I would want to remove my breasts. I was told surgery would make me happier, I was 14 years old.”
The US House of Representatives is investigating concerns that taxpayer-funded research on puberty blockers was withheld by Dr Olson-Kennedy because the results did not support transgender ideology.
The pro-trans researcher who was involved in the ‘Trans Youth Care’ (TYC) study admitted that she feared evidence showing puberty blockers did not improve participants’ mental health would be used by those who do not agree with the use of the drugs on gender-confused children.
Subcommittee Chairwoman Lisa McClain said the author’s refusal to publish taxpayer-funded research because it contradicts “her pre-existing biases” is “an irrefutable example of politicization of scientific research to further an ideological agenda”.